Braintree Laboratories
Clinical trials sponsored by Braintree Laboratories, explained in plain language.
-
Year-Long safety check for promising new acid reflux pill
Disease control CompletedThis study aimed to check the long-term safety of a daily pill called BLI5100 for people with acid reflux disease (GERD). It followed 400 patients who had already taken the drug in earlier studies for up to one full year. The main goal was to see how often side effects occurred d…
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug aims to heal and protect damaged esophagus
Disease control CompletedThis study tested a new daily pill called BLI5100 for people with erosive esophagitis, a condition where stomach acid damages the food pipe. The trial had two parts: first, to see if the drug could heal the damage over 8 weeks, and second, to see if it could keep the damage from …
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC